Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131569) titled 'Prospective, Randomized, Controlled Phase II Clinical Study of Nano-Crystalline Megestrol Acetate for Cachexia in Patients with Clinical Stage III Gastric/Gastroesophageal Junction Adenocarcinoma Undergoing Neoadjuvant Therapy with Serplulimab Combined with SOX' on Sept. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Cancer cachexia
Intervention:
Treatment Group:Nano-Crystalline Megestrol Acetate Oral Suspension + Serplulimab + SOX
Recruitment Status: Recruiting
Phase: 2
D...